Summary
This Nature Reviews Genetics article by Reay and Cairns surveys advancing methodologies for using genome-wide association studies (GWAS) to identify candidates for drug repurposing. The review appears to synthesise evidence on how large-scale genetic datasets can be leveraged to identify existing pharmaceutical compounds with potential efficacy in new disease contexts, bridging genomic discovery and clinical translation.
UK applicability
The methodological framework may be relevant to UK genomics research infrastructure and the NHS's interest in cost-effective therapeutic innovation; however, the paper's direct applicability to farming systems, soil health, and nutrient density—Pulse Brain's core domains—is limited.
Key measures
Not applicable to farming systems; review of GWAS methodology and drug repurposing applications
Outcomes reported
The paper examines methodological approaches and applications of GWAS for identifying existing drugs that may be repurposed to treat new indications. It synthesises evidence on how genetic association data can inform drug repositioning strategies.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.